<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31591" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Acute Traumatic Ischemia Hyperbaric Evaluation and Treatment</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Torp</surname>
            <given-names>Klaus D.</given-names>
          </name>
          <aff>Mayo Clinic Florida</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Murphy-Lavoie</surname>
            <given-names>Heather M.</given-names>
          </name>
          <aff>University Medical Center, LSU Medical School</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Klaus Torp declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Heather Murphy-Lavoie declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31591.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Trauma to a limb leads to direct tissue damage and local hypoxia due to edema, resulting in acute traumatic peripheral ischemia. The trauma can vary from mild to irreversible and may involve major blood vessels and nerve injuries. For severe injuries, amputations may be required. Sometimes, vascular repair and reimplantation are viable options. This activity reviews the indications, contraindications, and techniques involved in performing hyperbaric oxygen therapy and highlights the role of the interprofessional team in the care of patients undergoing this procedure.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Determine&#x000a0;the pathophysiology of acute, traumatic ischemia.</p></list-item><list-item><p>Assess&#x000a0;the complications associated with hyperbaric oxygen therapy for acute traumatic ischemia.</p></list-item><list-item><p>Identify&#x000a0;the contraindications to hyperbaric oxygen therapy for acute traumatic ischemia.</p></list-item><list-item><p>Communicate&#x000a0;a structured interprofessional team approach to provide effective care to and appropriate surveillance of patients undergoing hyperbaric oxygen therapy for acute traumatic ischemia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31591&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31591">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-31591.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Trauma to a limb, leading to direct tissue damage plus local hypoxic conditions from resulting edema, causes acute traumatic peripheral ischemia. The trauma can vary from mild to irreversible and may involve major blood vessels and nerve injuries. For severe injuries, amputations may&#x000a0;be required. Vascular repair and reimplantation may sometimes be required for the limb to be viable. Examples of trauma include crush injury&#x000a0;and thermal injury. Even without major vascular injuries, the tissue damage may lead to edema formation causing tissue hypoxia, leading to more edema formation. This vicious cycle can lead to compartment syndrome within poorly compliant muscle compartments, which then presents a surgical emergency to salvage the limb. Threatened flaps also fall into the category of acute traumatic peripheral ischemia, where hyperbaric oxygen has been shown to improve ischemia.<xref ref-type="bibr" rid="article-31591.r1">[1]</xref></p>
        <p>Surgical treatment and hyperbaric oxygen are not competing treatment modalities; they should be used in complementarity to provide the best outcome for the patient. Treating acute traumatic peripheral ischemia is&#x000a0;1 of the 13 approved hyperbaric oxygen&#x000a0;indications by the Undersea and Hyperbaric Medical Society.<xref ref-type="bibr" rid="article-31591.r2">[2]</xref>&#x000a0;It is also approved by the Centers for Medicare and Medicaid Services (CMS).</p>
        <p>The organization&#x000a0;states that when&#x000a0;a patient has acute traumatic peripheral ischemia&#x000a0;or when a patient is&#x000a0;suffering&#x000a0;from crush injuries,&#x000a0;and&#x000a0;surgeons have sutured severed limbs,&#x000a0;HBO therapy is a valuable, supplementary treatment physician&#x000a0;may use in combination with accepted, standard, therapeutic measures when patients may&#x000a0;lose function, limb, or life.</p>
      </sec>
      <sec id="article-31591.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>After an acute traumatic injury to a limb, injury to blood vessels leads to bleeding into tissues with subsequent coagulation and stasis in the vessels, which leads to hypoxia in the cells and the inability to maintain the metabolic demand important to maintain adequate intra-cellular water. The resulting edema causes increased pressure, causing more ischemia and hypoxia, leading to more cell death and extra-vascular water. Once blood flow is restored, subsequent ischemia-reperfusion injury occurs. The endothelial layer of the vessels becomes injured, and fluid extravasates, causing edema besides progressive obstruction of blood flow caused by neutrophils that adhere to the injured vessel wall.</p>
        <p>Hyperbaric oxygen works in multiple ways to help with those acute changes at the cellular level. First, it produces vasoconstriction by about 20%, which means less inflow of fluid (blood and plasma)&#x000a0;into the injured area, but since the dissolved oxygen in plasma is at least doubled (from that of breathing 100% oxygen by facemask), there is a net increase in oxygen delivery. This vasoconstriction results in less edema and increased oxygen diffusion distance. Hyperbaric oxygen also reduces the adhesion of neutrophils to the injured endothelium, which blunts the ischemia-reperfusion injury.<xref ref-type="bibr" rid="article-31591.r3">[3]</xref></p>
      </sec>
      <sec id="article-31591.s4" sec-type="Indications">
        <title>Indications</title>
        <p>Emergency surgical treatments such as revascularization and fracture stabilization should come before considering hyperbaric oxygen treatments. In some less urgent cases, hyperbaric oxygen treatments may help the surgeon better demarcate viable from dead tissue and thus minimize tissue loss and reduce the risk of amputations. The decision to use and frequency of hyperbaric oxygen should be made in close collaboration with the surgeon and&#x000a0;depends on the injury type, the injury severity, and patient host factors. It is best to use an objective grading system such as the Gustillo open-fracture crush injury grading system while adding a host factor function score that includes age, smoking, steroid use, ambulation status, and cardiovascular and kidney function. This&#x000a0;improves patient selection and the treatment algorithm, with the idea that even milder type injuries in a compromised host benefit from hyperbaric&#x000a0;oxygen as adjuvant therapy.<xref ref-type="bibr" rid="article-31591.r1">[1]</xref> Utilization review of hyperbaric treatments is an important part of the clinical care of those patients and is best done in close collaboration with the surgical and hyperbaric team after a certain number of predetermined hyperbaric treatments.<xref ref-type="bibr" rid="article-31591.r2">[2]</xref><xref ref-type="bibr" rid="article-31591.r4">[4]</xref><xref ref-type="bibr" rid="article-31591.r5">[5]</xref></p>
      </sec>
      <sec id="article-31591.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>There are no direct contraindications to hyperbaric oxygen in acute traumatic peripheral ischemia unless use delays&#x000a0;emergency, limb-saving operations such as revascularization or established compartment syndrome. There are few absolute contraindications, such as an unrelieved tension pneumothorax.</p>
      </sec>
      <sec id="article-31591.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>A pressure vessel and 100% oxygen are the tools to provide the benefits of hyperbaric oxygenation to the body. There are 2 types of pressure vessels: mono-place chambers and multi-place chambers. Mono-place chambers which can hold only&#x000a0;1 person.&#x000a0;They are usually made of a transparent acrylic tube with patient access through a metal door on&#x000a0;1 end. In mono-place chambers, 100% oxygen pressurizes the tube while the patient breathes the chamber's ambient oxygen. Some mono-place chambers have a separate breathing mask to provide air when air breaks are used. Mono-place chambers can be outfitted with ventilators, infusion pumps, and physiologic monitoring capabilities to provide high-acuity care. Mono-place chambers can fit into a standard hospital room and get piped into the hospital oxygen and air supply.</p>
        <p>Multi-place chambers are steel with acrylic viewing ports and can fit 2 to more than 20 people. They are pressurized with air while the patients breathe oxygen through a tight-fitting mask or a special hood sealed around the neck with a rubber neck dam. For any potential air breaks, the patients breathe the chamber air. These multi-place chambers are often large complexes with large compressors and reserve air and oxygen tanks.</p>
        <p>Both chamber types require special manufacturing and installation guidelines governed by special fire protection codes such as NFPA 99 in the United States. Facility accreditation of hyperbaric programs&#x000a0;is recommended and available through the Undersea and Hyperbaric Medical Society in the United States and some international locations. A transcutaneous oximeter can help determine the level of tissue oxygen tension on room air and during hyperbaric treatments and has been shown to have a positive predictive value of 0.88 for healing when a level over 200 mm Hg is reached during the treatment.<xref ref-type="bibr" rid="article-31591.r6">[6]</xref></p>
      </sec>
      <sec id="article-31591.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>For mono-place chambers,&#x000a0;1 specially trained outside attendant&#x000a0;may conduct and supervise up to 2 simultaneous hyperbaric chamber treatments and must be in continuous attendance outside the chambers. Multi-place chamber operations require both outside and inside specialty-trained attendant(s). Those inside attendants are breathing compressed chamber air and can be at risk for decompression illness, just like a scuba diver. Appropriate safety protocols and procedures must be in place to minimize that risk. An outside chamber operator is pressuring the chamber and constantly communicates with the inside attendant.</p>
        <p>A safety director must ensure maintenance and safe operations for the hyperbaric facility. A specialty-trained hyperbaric physician prescribes and supervises the pressure, time, and gas profiles of the hyperbaric treatments and examines the patient before and after the treatments. A specialty-trained hyperbaric&#x000a0;clinician&#x000a0;provides expert wound care, administers medications, and trains and educates the patients.</p>
      </sec>
      <sec id="article-31591.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>Safety procedures are required to minimize the introduction of static electricity, fuel, and ignition sources into the hyperbaric environment to decrease the fire risk. Everyone inside must wear cotton or cotton blend sheets and scrubs. Oily substances and alcohol must be avoided, and ignition sources are not allowed. In rare cases where the&#x000a0;patient has difficulty equalizing their ears during the pressure change, myringotomy tubes may have to be placed.</p>
        <p>Depending on the patient's injury, dressing changes and wound debridement may be required before entering the hyperbaric chamber. If patients require monitoring during the hyperbaric treatment, appropriate sensors must be applied and connected to pass-through connectors in the hull. If the patients require medications or infusions, those may need to be prepared for special infusion pumps. Communication between the primary surgical service and the hyperbaric medical team is paramount.</p>
      </sec>
      <sec id="article-31591.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>The attending hyperbaric medicine specialist prescribes the time, the pressure, and the breathing gas in a treatment table for the patient (and if the treatment is scheduled in a multi-place chamber, they also plan the dive profile for the inside attendants). Common treatment tables for acute traumatic peripheral ischemia are 2 atmospheres absolute (ATA) for 2 hours or 2.4 ATA for 90 minutes. The number of treatment tables that have been suggested varies by type of injury. For preventing ischemia-reperfusion injury, a single treatment may be sufficient. For crush injuries, a much more aggressive schedule of 8 treatments (1 treatment 3 times a day for 2 days, twice a day for 2 days, followed by once a day for another 2 days) may be required. For an impending compartment syndrome, 3 treatments (2 twice a day on the first day and 1 on the second day) are recommended. While any established compartment syndrome requires a fasciotomy, hyperbaric oxygen may still be useful following the fasciotomy to treat residual concerns such as&#x000a0;tissue ischemia, massive swelling, or nerve injury and may require twice daily treatments for up to 7 days.<xref ref-type="bibr" rid="article-31591.r2">[2]</xref></p>
      </sec>
      <sec id="article-31591.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Hyperbaric oxygen is usually well tolerated. Occasionally, patients who have difficulty equalizing may develop barotrauma to the ears. This can usually be managed with nasal decongestants and rarely requires myringotomy tubes to be placed by an otolaryngological surgeon. Pulmonary barotrauma is very rare; however, the possibility of pulmonary trauma should be considered&#x000a0;when patients develop chest pain on an ascent. Pulmonary and cerebral oxygen toxicity is typically not an issue with the relatively short exposures used for acute traumatic peripheral ischemias, but it can occur.</p>
      </sec>
      <sec id="article-31591.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Acute traumatic peripheral ischemia can be devastating and can lead to permanent loss of the limb or function. The cost of amputation with rehabilitation and the resulting loss of productivity far outweighs the cost of salvage and reconstruction,&#x000a0;even including appropriate hyperbaric oxygen therapy, which only adds about 10% to the overall cost.<xref ref-type="bibr" rid="article-31591.r7">[7]</xref>&#x000a0; Hyperbaric oxygen therapy is an often overlooked adjunct therapy to surgery and can help reduce the vicious cycle of edema, ischemia, and hypoxia, as well as reduce the deleterious effects of an ischemia-reperfusion injury. Unfortunately, hyperbaric oxygen is often only thought of to mitigate late complications, rather than applying it early helping to reduce tissue loss.<xref ref-type="bibr" rid="article-31591.r8">[8]</xref><xref ref-type="bibr" rid="article-31591.r9">[9]</xref><xref ref-type="bibr" rid="article-31591.r10">[10]</xref><xref ref-type="bibr" rid="article-31591.r11">[11]</xref><xref ref-type="bibr" rid="article-31591.r12">[12]</xref><xref ref-type="bibr" rid="article-31591.r10">[10]</xref></p>
      </sec>
      <sec id="article-31591.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of acute traumatic peripheral ischemia is challenging and complex. While it is in the realm of the trauma surgeon and the orthopedist, other important healthcare team members can offer expertise and skills to improve patient outcomes. Defining the patients who might best benefit from hyperbaric oxygen therapy, the Undersea and Hyperbaric Medical Society has suggested a treatment algorithm that considers the type and severity of trauma based on the Gustillo classification and patient host function factors that may influence the treatment decision.<xref ref-type="bibr" rid="article-31591.r2">[2]</xref>&#x000a0;The optimal treatment plan after a severe traumatic injury is best done&#x000a0;with&#x000a0;an interprofessional&#x000a0;approach.</p>
      </sec>
      <sec id="article-31591.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31591&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31591">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31591/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31591">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-31591.s14">
        <title>References</title>
        <ref id="article-31591.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zamboni</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Smoot</surname>
                <given-names>EC</given-names>
              </name>
            </person-group>
            <article-title>The effect of hyperbaric oxygen on reperfusion of ischemic axial skin flaps: a laser Doppler analysis.</article-title>
            <source>Ann Plast Surg</source>
            <year>1992</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>4</issue>
            <fpage>339</fpage>
            <page-range>339-41</page-range>
            <pub-id pub-id-type="pmid">1596067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31591.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strauss</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>The effect of hyperbaric oxygen in crush injuries and skeletal muscle-compartment syndromes.</article-title>
            <source>Undersea Hyperb Med</source>
            <year>2012</year>
            <season>Jul-Aug</season>
            <volume>39</volume>
            <issue>4</issue>
            <fpage>847</fpage>
            <page-range>847-55</page-range>
            <pub-id pub-id-type="pmid">22908841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31591.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buras</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Stahl</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Svoboda</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Reenstra</surname>
                <given-names>WR</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: the role of NOS.</article-title>
            <source>Am J Physiol Cell Physiol</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>278</volume>
            <issue>2</issue>
            <fpage>C292</fpage>
            <page-range>C292-302</page-range>
            <pub-id pub-id-type="pmid">10666024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31591.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000f6;ndahl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boulton</surname>
                <given-names>AJM</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric oxygen therapy in diabetic foot ulceration: Useless or useful? A battle.</article-title>
            <source>Diabetes Metab Res Rev</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>36 Suppl 1</volume>
            <fpage>e3233</fpage>
            <pub-id pub-id-type="pmid">31927787</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31591.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moghadam</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hieda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ramey</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Guilliod</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric Oxygen Therapy in Sports Musculoskeletal Injuries.</article-title>
            <source>Med Sci Sports Exerc</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>52</volume>
            <issue>6</issue>
            <fpage>1420</fpage>
            <page-range>1420-1426</page-range>
            <pub-id pub-id-type="pmid">31876671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31591.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strauss</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Bryant</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>GB</given-names>
              </name>
            </person-group>
            <article-title>Transcutaneous oxygen measurements under hyperbaric oxygen conditions as a predictor for healing of problem wounds.</article-title>
            <source>Foot Ankle Int</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>23</volume>
            <issue>10</issue>
            <fpage>933</fpage>
            <page-range>933-7</page-range>
            <pub-id pub-id-type="pmid">12398146</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31591.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MacKenzie</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Bosse</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Castillo</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Pollak</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>LX</given-names>
              </name>
              <name>
                <surname>Swiontkowski</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Kellam</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Sanders</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Starr</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>McAndrew</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Patterson</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Burgess</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Health-care costs associated with amputation or reconstruction of a limb-threatening injury.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>89</volume>
            <issue>8</issue>
            <fpage>1685</fpage>
            <page-range>1685-92</page-range>
            <pub-id pub-id-type="pmid">17671005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31591.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bouachour</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cronier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gouello</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Toulemonde</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Talha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alquier</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric oxygen therapy in the management of crush injuries: a randomized double-blind placebo-controlled clinical trial.</article-title>
            <source>J Trauma</source>
            <year>1996</year>
            <month>Aug</month>
            <volume>41</volume>
            <issue>2</issue>
            <fpage>333</fpage>
            <page-range>333-9</page-range>
            <pub-id pub-id-type="pmid">8760546</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31591.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garcia-Covarrubias</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>McSwain</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Van Meter</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Adjuvant hyperbaric oxygen therapy in the management of crush injury and traumatic ischemia: an evidence-based approach.</article-title>
            <source>Am Surg</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>71</volume>
            <issue>2</issue>
            <fpage>144</fpage>
            <page-range>144-51</page-range>
            <pub-id pub-id-type="pmid">16022014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31591.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Myers</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric oxygen therapy for trauma: crush injury, compartment syndrome, and other acute traumatic peripheral ischemias.</article-title>
            <source>Int Anesthesiol Clin</source>
            <year>2000</year>
            <season>Winter</season>
            <volume>38</volume>
            <issue>1</issue>
            <fpage>139</fpage>
            <page-range>139-51</page-range>
            <pub-id pub-id-type="pmid">10723673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31591.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakamura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Makiguchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Atomura</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yamatsu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shirabe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yokoo</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Changes in Skin Perfusion Pressure After Hyperbaric Oxygen Therapy Following Revascularization in Patients With Critical Limb Ischemia: A Preliminary Study.</article-title>
            <source>Int J Low Extrem Wounds</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-62</page-range>
            <pub-id pub-id-type="pmid">31478408</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31591.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conte</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Bradbury</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Kolh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Dick</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fitridge</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mills</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Ricco</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Suresh</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Murad</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Aboyans</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Aksoy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alexandrescu</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Azuma</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Belch</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bergoeing</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bjorck</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chakf&#x000e9;</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dawson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Debus</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Dueck</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Duval</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Eckstein</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Ferraresi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gambhir</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gargiulo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Geraghty</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Goode</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Hinchliffe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jetty</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Komori</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lavery</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lookstein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Menard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Misra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miyata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Moneta</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Munoa Prado</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Munoz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paolini</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pomposelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Robless</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schanzer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>De Ceniga</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Veller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vermassen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <collab>GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS), European Society for Vascular Surgery (ESVS), and World Federation of Vascular Societies (WFVS)</collab>
            </person-group>
            <article-title>Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.</article-title>
            <source>Eur J Vasc Endovasc Surg</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>58</volume>
            <issue>1S</issue>
            <fpage>S1</fpage>
            <page-range>S1-S109.e33</page-range>
            <pub-id pub-id-type="pmid">31182334</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
